Hemosil Readiplas Tin
Test, Time, Prothrombin. 510(k) K122584, from Instrumentation Laboratory CO (Bedford, MA). Product code GJS, class 2.
As of Nov 17, 2026, K122584 is an FDA 510(k) held by Instrumentation Laboratory CO, substantially equivalent on Mar 24, 2013 after 212 days, with 4 recalls tied to it in FDA's recall database.
- Substantially equivalent: Mar 24, 2013
- Review time: 212 days
- Recalls: 4
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFHemosIL ReadiPlasTin is an in vitro diagnostic thromboplastin reagent, based on recombinant human tissue factor, for the quantitative determination, in human citrated plasma, of Prothrombin Time (PT) and Fibrinogen, on the ACL TOP® Family of analyzers. The product is intended to be used for the evaluation of the extrinsic coagulation pathway and the monitoring of Oral Vitamin K Antagonist Therapy.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Hemosil Recombiplastin 2GK070005 · Instrumentation Laboratory CO · Aug 15, 2007
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- HemosIL ReadiPlasTinK213426 · Instrumentation Laboratory CO · Aug 16, 2022
Recalls
Recalls FDA ties to K122584, newest first; each opens FDA's recall record| Apr 8, 2022 | Z-1052-2022Variable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reagent, specifically HemosIL RecombiPlasTin… | Open, Classified |
| Oct 13, 2021 | Z-0276-2022The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or… | Open, Classified |
| Aug 1, 2018 | Z-0077-2019There is a potential for increased imprecision, out of range quality controls and prolonged sample results. | Terminated |
| Aug 2, 2017 | Z-0895-2018Instrumentation Laboratory Co. received customer reports of performance issues with some vials of Lot Nos. N1166235 and N0177760, including increased imprecision, out of range quality controls and prolonged sample… | Terminated |
Other GJS Clearances
The newest 510(k)s for the same product code; their median review was 299 days; see every GJS device- CoaguChek XS Plus SystemK253188 · Roche Diagnostics · Oct 24, 2025
- microINR SystemK251564 · Iline Microsystems, S.L. · Jul 21, 2025
- microINR SystemK243543 · Iline Microsystems, S.L. · Feb 27, 2025
- i-STAT PTplus Cartridge with the i-STAT 1 SystemK220282 · Abbott Laboratories · Jul 14, 2023
- microINR SystemK231711 · Iline Microsystems, S.L. · Jul 11, 2023
- STA- NeoPTimalK211485 · Diagnostica Stago S.A.S · Dec 23, 2022
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingK212779 · Coagusense, Inc. · Oct 5, 2022
- HemosIL ReadiPlasTinK213426 · Instrumentation Laboratory CO · Aug 16, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 24, 2012
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7750
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files